BACK TO FUND'S DETAIL PAGE
All Holdings
All Holdings
192 Total Holdings:
As of 3/31/24
All Holdings:
1 -
15 of
192
| Security Name | Asset Type |
Shares or Principal Amount |
Market Value |
Percent of Net Assets 
|
|---|---|---|---|---|
| Capital Group Central Cash Fund | Short Term | 5,337,180 | $533,504,530.00 | 4.7% |
| Novo Nordisk AS, Class B | Equity | 2,830,508 | $360,801,391.00 | 3.18% |
| Broadcom, Inc. | Equity | 240,990 | $319,410,556.00 | 2.81% |
| Microsoft Corp. | Equity | 651,713 | $274,188,693.00 | 2.42% |
| ASML Holding NV | Equity | 251,857 | $242,424,947.00 | 2.14% |
| Safran SA | Equity | 1,071,982 | $242,924,458.00 | 2.14% |
| AstraZeneca PLC | Equity | 1,513,059 | $203,918,557.00 | 1.8% |
| TotalEnergies SE | Equity | 2,735,629 | $187,321,127.00 | 1.65% |
| Apple, Inc. | Equity | 984,057 | $168,746,094.00 | 1.49% |
| SAP SE | Equity | 826,141 | $160,840,788.00 | 1.42% |
| Bristol-Myers Squibb Co. | Equity | 2,567,068 | $139,212,098.00 | 1.23% |
| Hilton Worldwide Holdings, Inc. | Equity | 628,117 | $133,983,637.00 | 1.18% |
| Alphabet, Inc., Class A | Equity | 881,675 | $133,071,208.00 | 1.17% |
| JPMorgan Chase & Co. | Equity | 662,032 | $132,605,010.00 | 1.17% |
| Abbott Laboratories | Equity | 1,156,141 | $131,406,986.00 | 1.16% |
All Holdings:
1 -
15 of
192